出典:Wikipedia
出典:『Wikipedia』 (2011/04/19 23:07 UTC 版)
Saredutant (SR-48,968) is a drug which acts as a NK2 receptor antagonist. It was under development by Sanofi-Aventis as a novel antidepressant and anxiolytic and made it to phase III clinical trials. However, in May 2009, Sanofi-Aventis published its quarterly results and announced the cessation of 14 research/development projects, among which was saredutant for the treatment of major depressive disorder.